ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Causal relationship between gut microbiota with subcutaneous and visceral adipose tissue: a bidirectional two-sample Mendelian Randomization study

Cao, Feng; Pan, Feng; Gong, Xin; Wang, Wen; Xu, Yanyan; Cao, Pengwei*; Wang, Yong*安徽医科大学; 南方医科大学; 1; y
Frontiers in Microbiology2023-10-31DOI: 10.3389/fmicb.2023.1285982
1被引4阅读
引用收藏
分享

摘要

BackgroundNumerous studies have revealed associations between gut microbiota and adipose tissue. However, the specific functional bacterial taxa and their causal relationships with adipose tissue production in different regions of the body remain unclear.MethodsWe conducted a bidirectional two-sample Mendelian Randomization (MR) study using aggregated data from genome-wide association studies (GWAS) for gut microbiota and adipose tissue. We employed methods such as inverse variance weighted (IVW), MR Egger, weighted median, simple mode, and weighted mode to assess the causal relationships between gut microbiota and subcutaneous adipose tissue (SAT) as well as visceral adipose tissue (VAT). Cochran's Q test, MR-Egger regression intercept analysis, and MR-PRESSO were used to test for heterogeneity, pleiotropy, and outliers of the instrumental variables, respectively. Reverse MR was employed to evaluate the reverse causal relationships between SAT, VAT, and gut microbiota with significant associations.ResultsIVW results demonstrated that Betaproteobacteria were protective factors for SAT production (OR = 0.88, 95% CI: 0.80-0.96, p = 0.005) and VAT production (OR = 0.91, 95% CI: 0.83-0.99, p = 0.030). Various bacterial taxa including Ruminococcaceae UCG002 (OR = 0.94, 95% CI: 0.89-0.99, p = 0.017), Methanobacteria class (OR = 0.96, 95% CI: 0.92-1.00, p = 0.029), and Burkholderiales (OR = 0.90, 95% CI: 0.83-0.98, p = 0.012) were associated only with decreased SAT production. Rikenellaceae RC9 gut group (OR = 1.05, 95% CI: 1.02-1.10, p = 0.005), Eubacterium hallii group (OR = 1.08, 95% CI: 1.01-1.15, p = 0.028), Peptococcaceae (OR = 1.08, 95% CI: 1.01-1.17, p = 0.034), and Peptococcus (OR = 1.05, 95% CI: 1.00-1.10, p = 0.047) were risk factors for SAT production. Meanwhile, Eubacterium fissicatena group (OR = 0.95, 95% CI: 0.91-0.99, p = 0.019), Turicibacter (OR = 0.93, 95% CI: 0.88-0.99, p = 0.022), and Defluviitaleaceae UCG011 (OR = 0.94, 95% CI: 0.89-0.99, p = 0.024) were protective factors for VAT production. Furthermore, Bacteroidetes (OR = 1.09, 95% CI: 1.01-1.17, p = 0.018), Eubacterium eligens group (OR = 1.09, 95% CI: 1.01-1.19, p = 0.037), Alloprevotella (OR = 1.05, 95% CI: 1.00-1.10, p = 0.038), and Phascolarctobacterium (OR = 1.07, 95% CI: 1.00-1.15, p = 0.042) were associated with VAT accumulation. Additionally, reverse MR revealed significant associations between SAT, VAT, and Rikenellaceae RC9 gut group (IVW: OR = 1.57, 95% CI: 1.18-2.09, p = 0.002) as well as Betaproteobacteria (IVW: OR = 1.14, 95% CI: 1.01-1.29, p = 0.029), both acting as risk factors. Sensitivity analyzes during bidirectional MR did not identify heterogeneity or pleiotropy.ConclusionThis study unveils complex causal relationships between gut microbiota and SAT/VAT, providing novel insights into the diagnostic and therapeutic potential of gut microbiota in obesity and related metabolic disorders.

学科与关键词

关键词
gut microbiotasubcutaneous adiposevisceral adiposeMendelian Randomizationcausal inference
相关
加载中…
  • Causal Associations between Gut Microbiota and Different Types of Dyslipidemia: A Two-Sample Mendelian Randomization Study
    Zhou, Xuyi; Lian, Peiqi; Liu, Hui; Wang, Yinghui; Zhou, Meijuan*; Feng, Zhijun*OncoImmunology, 2023, 15(20): 4445.
  • Exploring the causal effects of the gut microbiome on serum lipid levels: A two-sample Mendelian randomization analysis
    Guo, Gongjie; Wu, Yonglin; Liu, Yingjian; Wang, Zixian; Xu, Guifeng; Wang, Xipei; Liang, Feiqing; Lai, Weihua; Xiao, Xiao*; Zhu, Qian*; Zhong, Shilong*Frontiers in Microbiology, 2023, 14: 1113334.被引 8
  • Causal effects of gut microbiota on sepsis: a two-sample Mendelian randomization study
    Chen, Jie-Hai; Zeng, Li-Ying; Zhao, Yun-Feng; Tang, Hao-Xuan; Lei, Hang; Wan, Yu-Fei; Deng, Yong-Qiang*; Liu, Ke-Xuan*Frontiers in Microbiology, 2023, 14: 1167416.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Microbiology
发表日期
2023-10-31
卷期
第 14 卷
页码
1285982
DOI
10.3389/fmicb.2023.1285982
语言
ENGLISH
成果收录
SCIE
资助标注
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by The Research Projects of Anhui Medical University, grant number: no. 2022xkj173, and Key Research and Develop [2022xkj173]; Research Projects of Anhui Medical University [2022e07020049]; Key Research and Development Program of Anhui Province

作者

  • C

    Cao, Feng (第一作者)

    rwth aachen

  • P

    Pan, Feng

    2 · anhui med univ

查看全部 7 位作者收起作者
  • G

    Gong, Xin

    2 · anhui med univ

  • W

    Wang, Wen

    anhui med univ

  • X

    Xu, Yanyan

    2 · anhui med univ

  • C

    Cao, Pengwei (通讯)

    1 · anhui med univ

  • W

    Wang, Yong (通讯)

    2 · anhui med univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417